Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival

被引：0
|
作者：
S. H. Bakker
W. C. H. Jacobs
W. Pondaag
H. Gelderblom
R. A. Nout
P. D. S. Dijkstra
W. C. Peul
C. L. A. Vleggeert-Lankamp
机构：
[1] Leiden University Medical Center,Department of Neurosurgery
[2] Leiden University Medical Center,Department of Clinical Oncology
[3] Leiden University Medical Center,Departmant of Radiation Oncology
[4] Leiden University Medical Center,Department of Orthopedic Surgery
来源：
European Spine Journal | 2018年 / 27卷
关键词：
Chordoma; Epidemiology; Prognosis; Survival; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3043 / 3058
页数：15
相关论文
共 50 条
  • [1] Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival
    Bakker, S. H.
    Jacobs, W. C. H.
    Pondaag, W.
    Gelderblom, H.
    Nout, R. A.
    Dijkstra, P. D. S.
    Peul, W. C.
    Vleggeert-Lankamp, C. L. A.
    EUROPEAN SPINE JOURNAL, 2018, 27 (12) : 3043 - 3058
  • [2] A nomogram to predict the progression-free survival of clival chordoma
    Zhai, Yixuan
    Bai, Jiwei
    Li, Mingxuan
    Wang, Shuai
    Li, Chuzhong
    Wei, Xinting
    Zhang, Yazhuo
    JOURNAL OF NEUROSURGERY, 2021, 134 (01) : 144 - 152
  • [3] Prognostic factors in spinal chordoma: A systematic review
    Zou, Ming-Xiang
    Huang, Wei
    Wang, Xiao-Bin
    Li, Jing
    Lv, Guo-Hua
    Deng, You-Wen
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2015, 139 : 110 - 118
  • [4] A Hemorrhagic Clival Chordoma with a Long Progression-Free Survival
    Vilela, Marcelo D.
    Pedrosa, Hugo A. S.
    Dias Filho, Marco Antonio
    WORLD NEUROSURGERY, 2017, 105 : 1042.e1 - 1042.e4
  • [5] Tumor Growth Rate as a New Predictor of Progression-Free Survival After Chordoma Surgery
    Passeri, Thibault
    di Russo, Paolo
    Champagne, Pierre-Olivier
    Bernat, Anne-Laure
    Cartailler, Jerome
    Guichard, Jean Pierre
    Mammar, Hamid
    Giammattei, Lorenzo
    Adle-Biassette, Homa
    George, Bernard
    Mandonnet, Emmanuel
    Froelich, Sebastien
    NEUROSURGERY, 2021, 89 (02) : 291 - 299
  • [6] Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
    Clarke, Jennifer L.
    Ennis, Michele M.
    Yung, W. K. Alfred
    Chang, Susan M.
    Wen, Patrick Y.
    Cloughesy, Timothy F.
    DeAngelis, Lisa M.
    Robins, H. Ian
    Lieberman, Frank S.
    Fine, Howard A.
    Abrey, Lauren
    Gilbert, Mark R.
    Mehta, Minesh
    Kuhn, John G.
    Aldape, Kenneth D.
    Lamborn, Kathleen R.
    Prados, Michael D.
    NEURO-ONCOLOGY, 2011, 13 (10) : 1118 - 1124
  • [7] Intermediate clinical endpoints: A bridge between progression-free survival and overall survival in ovarian cancer trials
    Matulonis, Ursula A.
    Oza, Amit M.
    Ho, Tony W.
    Ledermann, Jonathan A.
    CANCER, 2015, 121 (11) : 1737 - 1746
  • [8] Prognostic factors related to overall survival in adolescent and young adults with medulloblastoma: A systematic review
    Yan, Han
    Zabih, Veda
    Bartels, Ute
    Das, Sunit
    Nathan, Paul
    Gupta, Sumit
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [9] Prognostic factors for survival in Ewing sarcoma: A systematic review
    Bosma, S. E.
    Ayu, O.
    Fiocco, M.
    Gelderblom, H.
    Dijkstra, P. D. S.
    SURGICAL ONCOLOGY-OXFORD, 2018, 27 (04): : 603 - 610
  • [10] Nomograms for predicting progression-free survival and overall survival after surgery and concurrent chemoradiotherapy for glioblastoma: a retrospective cohort study
    Zheng, Lin
    Zhou, Zhi-Rui
    Shi, Minghan
    Chen, Haiyan
    Yu, Qian-Qian
    Yang, Yang
    Liu, Lihong
    Zhang, Lili
    Guo, Yinglu
    Zhou, Xiaofeng
    Li, Chao
    Wei, Qichun
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (07)
12345